Mario Capecchi and Oliver Smithies of the US and Martin Evans of Britain won the Nobel Prize for Medicine yesterday for their work in creating "knockout mice," the 21st-century testbed for biomedical research.
The trio were honored for discovering how to genetically manipulate mouse embryonic stem cells, leading to lab rodents that replicate human disease, the Nobel jury said in its citation.
Their "ground-breaking discoveries concerning embryonic stem cells and DNA recombination in mammals ... led to the creation of an immensely powerful technology," the committee said.
The discovery is technically called gene targeting but is commonly known as gene "knockout."
Engineered mice provide researchers with a lab model that yields insights into the fundamentals of diseases ranging from Alzheimer's to cancer and the response to new drugs, the jury said.
Thanks to their work, scientists can now determine the role of specific genes, a breakthrough that has "revolutionized life science," it said.
"Gene targeting in mice has pervaded all fields of biomedicine. Its impact on the understanding of gene function and its benefits to mankind will continue to increase over many years to come," it said.
To date, more than 10,000 mice genes -- approximately half of the genes in the mammalian genome -- have been knocked out.
Disabling, or knocking out, a gene is a two-step process.
The first is to snip out a functioning gene from the animal's genome, using chemical "scissors" such as an enzyme.
The next is to replace that gene with the modified one -- the gene whose flaws will cause the disease to be studied.
The big challenge is getting this introduced stretch of DNA to find the corresponding slot in the chromosome and then fit in snugly.
Little more than two decades ago, the prevailing wisdom was that the task was impossible in mammalian cells and that the DNA would insert itself in the chromosome almost randomly.
The Nobel laureates found a way to do this. In the 1980s, Evans isolated mice embryonic stem cells -- the all-purpose master cells whose manipulation could create in theory any mutation of choice.
In the meantime, Capecchi and Smithies, working independently of each other, found a way to target genes by a technique called "homologous recombination."
"Homologous" means that the introduced DNA sequence lines up with its mirror target sequence in the mouse chromosome, while "recombination" means the incoming and target sequences break and then rejoin.
"The award is very exciting and particularly appropriate," said Steve Brown, a leading scientist at the Mammalian Genetics Unit of Britain's Medical Research Council.
"Our ability to knock out -- to lose the function -- of a gene in the mouse genome has been absolutely critical in understanding the genetic basis of human disease in all areas."
The medicine prize is the first award to be announced in this year's Nobel season.
The physics prize is to be announced today followed by the chemistry prize tomorrow. The literature prize will be announced on Thursday and the peace prize on Friday.
The economics prize wraps up the season next Monday.
RESILIENCE: Deepening bilateral cooperation would extend the peace sustained over the 45 years since the Taiwan Relations Act, Greene said Taiwan-US relations are built on deep economic ties and shared values, American Institute in Taiwan (AIT) Director Raymond Greene said yesterday, adding that strengthening supply chain security in critical industries, enhancing societal resilience through cooperation and deepening partnerships are key to ensuring peace and stability for Taiwan in the years ahead. Greene made the remarks at the National Security Youth Forum, organized by National Taiwan University’s National Security and Strategy Studies Institution in Taipei. In his address in Mandarin Chinese, Greene said the Taiwan-US relationship is built on deep economic ties and shared interests, and grows stronger through the enduring friendship between
GAINING STEAM: The scheme initially failed to gather much attention, with only 188 cards issued in its first year, but gained popularity amid the COVID-19 pandemic Applications for the Employment Gold Card have increased in the past few years, with the card having been issued to a total of 13,191 people from 101 countries since its introduction in 2018, the National Development Council (NDC) said yesterday. Those who have received the card have included celebrities, such as former NBA star Dwight Howard and Australian-South Korean cheerleader Dahye Lee, the NDC said. The four-in-one Employment Gold Card combines a work permit, resident visa, Alien Resident Certificate (ARC) and re-entry permit. It was first introduced in February 2018 through the Act Governing Recruitment and Employment of Foreign Professionals (外國專業人才延攬及雇用法),
The Ministry of Transportation and Communications yesterday said that it would redesign the written portion of the driver’s license exam to make it more rigorous. “We hope that the exam can assess drivers’ understanding of traffic rules, particularly those who take the driver’s license test for the first time. In the past, drivers only needed to cram a book of test questions to pass the written exam,” Minister of Transportation and Communications Chen Shih-kai (陳世凱) told a news conference at the Taoyuan Motor Vehicle Office. “In the future, they would not be able to pass the test unless they study traffic regulations
EUROPEAN TARGETS: The planned Munich center would support TSMC’s European customers to design high-performance, energy-efficient chips, an executive said Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s largest contract chipmaker, yesterday said that it plans to launch a new research-and-development (R&D) center in Munich, Germany, next quarter to assist customers with chip design. TSMC Europe president Paul de Bot made the announcement during a technology symposium in Amsterdam on Tuesday, the chipmaker said. The new Munich center would be the firm’s first chip designing center in Europe, it said. The chipmaker has set up a major R&D center at its base of operations in Hsinchu and plans to create a new one in the US to provide services for major US customers,